Inhaled Glucocorticoid Flops for Speeding COVID Recovery in Outpatients
Inhaled fluticasone furoate failed to shorten recovery time for non-hospitalized adults with COVID-19, new data from the adaptive ACTIV-6 trial found. When used daily for 2 weeks, a quicker COVID-19 recovery time — considered at least 3 consecutive days without symptoms — was no more likely with fluticasone furoate than with placebo (HR 1.01, 95% […]
Intranasal Saline May Suffice for Some Kids’ Sleep-Disordered Breathing
Intranasal mometasone furoate was no better than saline for resolving symptoms of sleep-disordered breathing (SDB) in children, but either treatment may reduce the need for specialty care or surgery, the randomized MIST trial suggested. After 6 weeks of daily treatment, the proportion experiencing the study’s primary endpoint — resolution of significant SDB symptoms — was […]